via NIH
Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue. The teams collaborated closely with Janssen Pharmaceutica, N.V. The antiviral molecule is exceptionally effective against all known dengue variants and could be used for therapeutic and prevention purposes.
The teams have published their findings in Nature.
Each year, dengue infects up to 400 million people, sickens up to 100 million, and kills thousands. Symptoms of the disease include a high fever and severe muscle and joint pain. Some patients also suffer from subcutaneous bleeding or capillary leakage.
The disease is caused by the mosquito-borne dengue virus, which is found in nearly all (sub)tropical regions, but especially in Latin America and Asia. The frequency of outbreaks continues to grow, and the virus is expected to impact billions more in the coming decades as the virus spreads to other regions due to climate change and other global trends. In 2019, the World Health Organization already included dengue in its list of ten threats to global health.
No antiviral drugs are currently available to prevent or treat dengue. This may change thanks to the breakthrough discovery of teams led by Johan Neyts (Rega Institute at KU Leuven) and Patrick Chaltin (CD3/CISTIM Leuven vzw), which was carried forward in collaboration with Marnix van Loock and team at our strategic partner Janssen Pharmaceutica, N.V.
Blocking the ‘copier’ of the virus
The antiviral has a unique mechanism, explains Professor Johan Neyts of the Rega Institute at KU Leuven. “Together with the research group of Professor Ralf Bartenschlager from Heidelberg University, we demonstrated that our inhibitor prevents the interaction between two viral proteins that are part of a kind of copier for the genetic material of the virus. If this interaction is blocked, the virus can no longer copy its genetic material. As a result, no new virus particles are produced.”
The optimisation process involved about 2000 steps. Years of intensive collaboration have now resulted in an ultra-potent dengue inhibitor that we are proud to present.
– Patrick Chaltin (CD3)
Together with Professor Xavier de Lamballerie (Aix-Marseille University), the team proved that the antiviral is very effective against all known variants of the dengue virus.
The researchers tested the inhibitor in mice as well. Suzanne Kaptein (Rega Institute at KU Leuven): “Even a low dose of the drug administered via the oral route proved to be very effective. What is more, the treatment is still effective when the infection is already at its peak. In these cases, the number of virus particles in the blood dropped drastically within 24 hours after the start of the treatment. This goes to show how extremely potent the antiviral drug is.”
Also suitable for prevention
Research in mice suggests that the inhibitor could also be used for prevention purposes. These findings are cause for optimism, as the existing dengue vaccine only offers partial protection.
Professor Johan Neyts (KU Leuven): “Potent and safe dengue drugs that can be easily taken as tablets could offer anyone effective protection for a certain period of time. Think of people living in areas with an ongoing dengue outbreak, for instance: they could take a dengue drug for a couple of days or weeks. The tablets could also protect travellers or NGO workers during their stay in high-risk regions.”
The antiviral drug will be developed in an easy-to-administer formulation that can be optimised for the treatment and prevention of the disease in dengue-endemic tropical and subtropical regions.
Search of many years
The development of the antiviral was a long haul, says Professor Johan Neyts (KU Leuven). “We started this project in 2009. First, we examined many thousands of molecules in a compound library of the Centre for Drug Design and Discovery (CD3) to find one or more molecules that inhibit the virus in lab-grown cells. In other words: we started looking for a needle in a haystack. As soon as we were able to identify such molecules, the medicinal chemists at CD3 could start to work with them. They created many versions of the molecules to boost their efficacy against the virus.”
There are four types of dengue viruses, and the molecule needed to be equally effective against all four of them, adds Patrick Chaltin from the Centre for Drug Design and Discovery. “It was no easy feat to reach that goal: the optimisation process involved about 2000 steps. Years of intensive collaboration have now resulted in an ultra-potent dengue inhibitor that we are proud to present.”
Original Article: KU Leuven develops very potent antiviral against dengue
More from: Catholic University of Leuven | Heidelberg University | Aix-Marseille University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Dengue fever
- Dengue sparks concern in Latin Americaon May 1, 2024 at 5:01 pm
A dengue fever patient walks inside a hospital on the outskirts of Lima, Peru, on April 17. JUAN CARLOS CISNEROS/AFP The dengue outbreak across Latin America has reached alarming levels with reported ...
- Health warning to travellers heading to Bali after surge in dengue feveron May 1, 2024 at 1:59 pm
Travellers heading to Bali have been issued with a health warning after a surge of people returned home to Australia with dengue fever.
- Pacific countries warned to focus on dengue fever preventionon May 1, 2024 at 11:12 am
As cyclone season ends, Pacific communities across the region are now being warned to focus on dengue fever prevention.
- Health warning to travellers heading to Bali after surge of people return with dengue feveron May 1, 2024 at 10:12 am
Western Australia has recorded 138 cases of dengue fever this year, twice the number of cases compared to the same time last year. WA Health said most of those cases were acquired in Indonesia, which ...
- Dengue fever outbreak: How to stay safe on a Pacific tripon May 1, 2024 at 10:03 am
A Pacific Island winter break might be ideal, but care needs to be taken not to contract or spread viruses like dengue fever. Photo / Getty Images Samoa has officially declared a dengue fever outbreak ...
Go deeper with Google Headlines on:
Dengue fever
[google_news title=”” keyword=”Dengue fever” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Dengue virus
- Health warning to travellers heading to Bali after surge in dengue feveron May 1, 2024 at 1:59 pm
Travellers heading to Bali have been issued with a health warning after a surge of people returned home to Australia with dengue fever.
- Health warning to travellers heading to Bali after surge of people return with dengue feveron May 1, 2024 at 10:12 am
WA Health has recorded a surge in people returning from Bali with dengue fever. Photo: iStock Dengue virus is transmitted to people via the bite of an infected mosquito and while most people will have ...
- West Australians warned of dengue fever surge in Bali ahead of popular tourism seasonon April 30, 2024 at 11:34 pm
West Aussies planning trips to Bali are being warned of the surge in Dengue Fever cases derived from mosquito bites ahead of the tourist hotspot’s high season.
- Uttarakhand Health Department notifies guidelines for dengue and chikungunya managementon April 30, 2024 at 9:00 pm
The Health Secretary said that all other departments also have an important role in the proper prevention and control of dengue and chikungunya disease. All the departments should carry out ...
- Immune cell interaction study unlocks novel treatment targets for chikungunya viruson April 29, 2024 at 12:15 pm
Researchers have long known that the body's immune system plays a critical role in fighting off chikungunya virus (CHIKV), but how exactly immune cells coordinate their response has been a ...
Go deeper with Google Headlines on:
Dengue virus
[google_news title=”” keyword=”dengue virus” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]